1-4 of 4
Robert A. Kirken
Close
Sort by
Journal Articles

Autocrine release of interleukin-9 promotes Jak3-dependent survival of ALK + anaplastic large-cell lymphoma cells

Lin Qiu, Raymond Lai, Quan Lin, Esther Lau, David M. Thomazy, Daniel Calame, Richard J. Ford, Larry W. Kwak, Robert A. Kirken, Hesham M. Amin
Journal: Blood
Blood (2006) 108 (7): 2407–2415.
https://doi.org/10.1182/blood-2006-04-020305
Published: 2006
Journal Articles

Selective inhibitor of Janus tyrosine kinase 3, PNU156804, prolongs allograft survival and acts synergistically with cyclosporine but additively with rapamycin

Stanislaw M. Stepkowski, Rebecca A. Erwin-Cohen, Fariba Behbod, Mou-Er Wang, Xienui Qu, Neelam Tejpal, Zsuzsanna S. Nagy, Barry D. Kahan, Robert A. Kirken
Journal: Blood
Blood (2002) 99 (2): 680–689.
https://doi.org/10.1182/blood.V99.2.680
Published: 2002
Journal Articles

Selective disruption of interleukin 4 autocrine-regulated loop by a tyrosine kinase inhibitor restricts activity of T-helper 2 cells

Li Hua Wang, Robert A. Kirken, Xiao Yi Yang, Rebecca A. Erwin, Luis DaSilva, Cheng-Rong Yu, William L. Farrar
Journal: Blood
Blood (2000) 95 (12): 3816–3822.
https://doi.org/10.1182/blood.V95.12.3816
Published: 2000
Journal Articles

Targeted disruption of Stat6 DNA binding activity by an oligonucleotide decoy blocks IL-4–driven T H 2 cell response

Li Hua Wang, Xiao Yi Yang, Robert A. Kirken, James H. Resau, William L. Farrar
Journal: Blood
Blood (2000) 95 (4): 1249–1257.
https://doi.org/10.1182/blood.V95.4.1249.004k39_1249_1257
Published: 2000